Show simple item record

dc.contributor.authorPan American Health Organizationen_US
dc.date.accessioned2018
dc.date.available2018
dc.date.issued1993es_ES
dc.identifier.govdocEB93/20es_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/43544
dc.description.abstractExecutive Board Session, 93. World Health Organization; 17-26 Jan. 1994en_US
dc.subjectIndustria Farmacéuticaes_ES
dc.subjectFarmaciaes_ES
dc.subjectOrganización Mundial de la Saludes_ES
dc.titleImplementation of WHO's revised drug strategy: good manufacturing practices and role of the pharmacist: report by the Director-Generalen_US
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenameExecutive Board Session, 93es_ES


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record